Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus
about
Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and CancersPlasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities studyEstimation of insulin sensitivity in children: methods, measures and controversiesPathogenesis of insulin resistance in skeletal muscle.AMP-activated protein kinase (AMPK)α2 plays a role in determining the cellular fate of glucose in insulin-resistant mouse skeletal muscle.Insulin receptor substrate-1 variants in non-insulin-dependent diabetesThe importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study.Microarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications.Plasma Lactate Levels Increase during Hyperinsulinemic Euglycemic Clamp and Oral Glucose Tolerance Test.Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.Association of blood lactate with carotid atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI StudyIntracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals.Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.Lactate, a Neglected Factor for Diabetes and Cancer Interaction.Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents.Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose.Sprint interval training decreases left-ventricular glucose uptake compared to moderate-intensity continuous training in subjects with type 2 diabetes or prediabetes.Tissue differences in the response of the pyruvate dehydrogenase complex to a glucose load during the development of obesity in gold-thioglucose-obese mice.Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients.Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes.Effects of fluvastatin treatment on insulin sensitivity in patients with hyperlipidaemia.Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects.Pathways for glucose disposal after meal ingestion in humans.Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart.Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs.Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.The relationship between left ventricular mass index and insulin sensitivity, postprandial glycaemia, and fasting serum triglyceride and adiponection levels in patients with type 2 diabetes.Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism.Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure.Effect of Progressive Weight Loss on Lactate Metabolism: A Randomized Controlled Trial.Effect of fasting on the intracellular metabolic partition of intravenously infused glucose in humans.The acute impact of ethanol on glucose, insulin, triacylglycerol,and free fatty acid responses and insulin sensitivity in type 2 diabetes.The metabolic syndrome and cardiovascular disease
P2860
Q26822845-9591B040-3503-434D-ABE5-55A327C4F545Q33668158-65CD1B0C-EB76-4836-A3F5-DDA8D2784CDBQ33670227-19E9B1AC-5995-4B1A-94EB-FAA519FAEFB3Q33812448-62C06C44-B76A-4577-A848-B0435BDD9232Q33822976-806448B9-BF71-4BA0-88CB-9D02620D012EQ34184582-4417B704-A735-432E-940B-0CFC4CF554D8Q34292419-50825F2D-CEEF-4B1B-9DA7-6B69E6CB92A4Q34354390-A0FBF2FB-49BE-4AC9-BDB0-85B618BCA737Q34974769-8579AAA6-8706-4FFF-9741-308A86E7B7BFQ35563398-486D5F8B-8F56-4E66-B839-F8A96E5E230CQ35762624-B2ED454E-D2AB-4FAE-BCCE-8576FD9BA569Q36854842-6A53C0FA-D894-42FE-997F-8C6D5B8BE47CQ37357051-A3CCFF73-EE08-469F-8F76-C793932DB8BAQ37372990-DF2D48BD-649A-41B4-93A6-6C089465E5F5Q37384513-8DF26492-4DD7-465C-9F9A-79C7D3E636D4Q37547661-A8ECEBC0-1E4E-42AA-B3CF-1E464433D90BQ37624257-4E137776-0B53-408C-B8BE-EAFB2C7B06EFQ38191195-D3E02684-1FE0-4547-920E-2ED4DCEE81E5Q38247935-C802E8B9-383A-4AF1-8AA7-513E3F8B5CE4Q39133938-15A60B8A-83C6-4C7D-BCD8-9332616E00FEQ39489343-1122912E-9C73-4455-BD14-60864ECB7C26Q41621302-276EB549-D624-4DA1-8FCD-F238239C4756Q42019713-8372A0C2-2A45-4B13-8BDB-A97C1C19D9C4Q43524361-66FD80F6-1022-42B4-B09E-7B2009A0051DQ43674607-EF1C7B97-FBB0-4B47-B76C-C65B70292DCFQ43819493-F3A3ED70-3CBC-4735-A9AF-A6A82D475681Q43938829-348C77C4-922F-4974-BAF6-68121A6F0260Q44016355-81AE72CD-513A-47E8-BA81-924D80397EE1Q44244726-D5DF709D-F1D8-418F-8C52-C68AE74DB524Q44470060-A9739657-2CD5-45AF-8AE3-5C587669164BQ45259192-DBFD4FE4-82D2-4EB5-B403-8D1F30645FE7Q46654997-0397E619-4215-457C-85BF-992A430FD37CQ46846855-79855B69-2231-4435-96D5-D116ABEAA267Q46886494-D1C08D10-44D6-4377-8992-A226E339B1A8Q48749181-F7D337B9-18EB-4E73-B080-48D7E1794A33Q51246632-E3F6A4A4-6CAF-4BF3-BC3F-6476183A7AABQ51559868-6E7C8BAA-478F-448F-92FE-7646B2A51FE3Q51578633-B8C6DC19-2731-445D-A379-45CBE8292578Q58271154-D8D0E5E2-581D-4181-9FB9-70B98A883AC0
P2860
Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus
description
1993 nî lūn-bûn
@nan
1993 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Characterization of cellular d ...... n-dependent) diabetes mellitus
@ast
Characterization of cellular d ...... n-dependent) diabetes mellitus
@en
type
label
Characterization of cellular d ...... n-dependent) diabetes mellitus
@ast
Characterization of cellular d ...... n-dependent) diabetes mellitus
@en
prefLabel
Characterization of cellular d ...... n-dependent) diabetes mellitus
@ast
Characterization of cellular d ...... n-dependent) diabetes mellitus
@en
P2093
P2860
P356
P1476
Characterization of cellular d ...... n-dependent) diabetes mellitus
@en
P2093
P2860
P304
P356
10.1172/JCI116226
P407
P577
1993-02-01T00:00:00Z